(Q40766940)
Statements
The phosphatidylinositide 3'-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C (English)
A Tenzer
D Zingg
S Rocha
D Fabbro
C Glanzmann
P A Schubiger
S Bodis